4/14
11:56 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
4/14
11:56 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
4/14
11:56 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
4/14
10:50 am
idya
Rating for IDYA
Medium
Report
Rating for IDYA
4/14
10:50 am
idya
Rating for IDYA
Medium
Report
Rating for IDYA
4/14
10:17 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
4/14
10:17 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
4/14
09:45 am
idya
Rating for IDYA
Medium
Report
Rating for IDYA
4/14
09:45 am
idya
Rating for IDYA
Medium
Report
Rating for IDYA
4/14
09:06 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
4/14
09:06 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
4/14
08:57 am
idya
IDEAYA Biosciences (IDYA) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Low
Report
IDEAYA Biosciences (IDYA) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
4/14
08:57 am
idya
IDEAYA Biosciences (IDYA) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Low
Report
IDEAYA Biosciences (IDYA) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
3/31
10:20 am
idya
IDEAYA Biosciences (IDYA) had its "outperform" rating reaffirmed by Wedbush. They now have a $52.00 price target on the stock.
Low
Report
IDEAYA Biosciences (IDYA) had its "outperform" rating reaffirmed by Wedbush. They now have a $52.00 price target on the stock.
3/31
10:20 am
idya
IDEAYA Biosciences (IDYA) had its "outperform" rating reaffirmed by Wedbush. They now have a $52.00 price target on the stock.
Low
Report
IDEAYA Biosciences (IDYA) had its "outperform" rating reaffirmed by Wedbush. They now have a $52.00 price target on the stock.
3/31
10:05 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
3/31
10:05 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
2/19
03:01 pm
idya
Rating for IDYA
Low
Report
Rating for IDYA
2/19
03:01 pm
idya
Rating for IDYA
Low
Report
Rating for IDYA
2/19
07:20 am
idya
IDEAYA Biosciences (NASDAQ:IDYA) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
IDEAYA Biosciences (NASDAQ:IDYA) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
2/18
11:37 am
idya
IDEAYA Biosciences (NASDAQ:IDYA) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $49.00 price target on the stock.
Low
Report
IDEAYA Biosciences (NASDAQ:IDYA) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $49.00 price target on the stock.
2/18
11:37 am
idya
IDEAYA Biosciences (NASDAQ:IDYA) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $49.00 price target on the stock.
Low
Report
IDEAYA Biosciences (NASDAQ:IDYA) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $49.00 price target on the stock.
2/18
11:15 am
idya
IDEAYA Biosciences (NASDAQ:IDYA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
IDEAYA Biosciences (NASDAQ:IDYA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
2/18
10:55 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
2/18
10:55 am
idya
Rating for IDYA
Low
Report
Rating for IDYA